HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiang-Shu Jin Selected Research

VDA-P protocol

12/2015[Imatinib Combined with VP Low Dose Regiment for Treating Newly Diagnosed Adult Patients with Ph-positive ALL].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiang-Shu Jin Research Topics

Disease

2Hematologic Neoplasms (Hematological Malignancy)
02/2017 - 10/2009
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
06/2021
1Disease Progression
02/2020
1Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2020
1Neoplasms (Cancer)
02/2020
1Mycoses (Diseases, Fungus)
02/2017
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2016
1Diarrhea
12/2015
1Edema (Dropsy)
12/2015
1Fever (Fevers)
12/2015
1Infections
12/2015
1Neutropenia
12/2015
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2015

Drug/Important Bio-Agent (IBA)

1Small Interfering RNA (siRNA)IBA
02/2020
1Biomarkers (Surrogate Marker)IBA
02/2020
1Peptidylprolyl Isomerase (Prolyl Isomerase)IBA
02/2020
1Amphotericin B (Amphotericin)FDA LinkGeneric
02/2017
1Tyrosine Kinase InhibitorsIBA
12/2016
1Imatinib Mesylate (Gleevec)FDA Link
12/2015
1Therapeutic UsesIBA
12/2015

Therapy/Procedure

3Therapeutics
02/2020 - 12/2016
1Cell Transplantation
06/2021
1Induction Chemotherapy
12/2015
1Transplantation
12/2015
1VDA-P protocol
12/2015
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
10/2009